Besides, we demonstrated, in our recent study, an elevated frequency of aβ2GPI‐IgA in patients with hepatitis C.17Garcia‐Arellano et al.30found that the most frequent aPL was aβ2GPI‐IgA on COVID‐19 patients with a frequency of 73.9%. This evidence concerns the gene CD79A and COVID-19.